FDA Import Refusals in New Jersey — Page 29

1,577 import refusals total in NJ

Browse FDA import refusals for shipments tied to firms in New Jersey. RegDataLab tracks 1,577 import refusals from official FDA sources, updated on an ongoing basis.

FDA Import Refusals in New Jersey (page 29 of 32)
Import refusalsDetails
112-6625351-7/1/1 — Par Pharmaceutical Inc.Jun 28, 2005 — United States
112-6787085-5/1/1 — Catalent Pharma SolutionsJun 28, 2005 — United States
G73-2008820-4/5/1 — The Ralph Lauren Womenswear CoJun 10, 2005 — United States
112-6584569-3/1/1 — Chattem IncJun 1, 2005 — United States
112-6915528-9/1/1 — Simirex IncMay 31, 2005 — United States
112-6478390-3/1/1 — Merck, Inc.May 24, 2005 — United States
112-6800786-1/1/1 — Bristol Myers SquibbMay 23, 2005 — United States
112-6432939-2/1/1 — Pharmacia & Upjohn Co LlcMay 19, 2005 — United States
DQ4-9096302-1/3/1 — HoneywellMay 19, 2005 — United States
112-6878797-5/2/1 — Bristol-Myers Squibb CompanyMay 17, 2005 — United States
110-5163467-5/1/1 — Givaudan Flavors CorporationApr 13, 2005 — United States
112-6019776-9/1/1 — Anthra Pharmaceuticals, Inc.Mar 29, 2005 — United States
112-6115929-7/6/1 — Bayer Healthcare, LLCMar 21, 2005 — United States
112-6032687-1/1/1 — Bristol-Myers Squibb CompanyMar 7, 2005 — United States
112-5693636-0/3/1 — Novartis Pharmaceuticals CorporationMar 4, 2005 — United States
112-5672290-1/1/1 — Maximun Human Performance, IncMar 3, 2005 — United States
551-2980556-5/1/1 — Symrise, Inc.Feb 28, 2005 — United States
551-2980557-3/1/1 — Symrise, Inc.Feb 28, 2005 — United States
582-8683876-9/1/1 — Unilever North America Supply Chain Company, LLCFeb 7, 2005 — United States
112-5142220-0/1/1 — PfizerJan 7, 2005 — United States
112-5041634-4/1/1 — Novartis Pharmaceuticals CorporationJan 6, 2005 — United States
112-2796531-6/2/1 — James Alexander Corp.Dec 22, 2004 — United States
112-4716369-4/1/1 — Celgene Cellular TherapeuticsDec 21, 2004 — United States
551-3890761-8/1/3 — L'Oreal USA Products IncDec 20, 2004 — United States
551-3890761-8/1/4 — L'Oreal USA Products IncDec 20, 2004 — United States
551-3890761-8/1/5 — L'Oreal USA Products IncDec 20, 2004 — United States
551-3890761-8/1/6 — L'Oreal USA Products IncDec 20, 2004 — United States
551-3890761-8/1/2 — L'Oreal USA Products IncDec 20, 2004 — United States
551-3890761-8/1/1 — L'Oreal USA Products IncDec 20, 2004 — United States
112-4624443-8/1/1 — Catalent Pharma SolutionsNov 19, 2004 — United States
112-4551833-7/1/1 — Roche Consumer HealthNov 18, 2004 — United States
HL3-9042210-9/2/2 — PanasonicOct 6, 2004 — United States
551-3277678-7/2/5 — L'Oreal USA Products IncAug 26, 2004 — United States
551-3277678-7/2/4 — L'Oreal USA Products IncAug 26, 2004 — United States
551-3277678-7/2/3 — L'Oreal USA Products IncAug 26, 2004 — United States
551-3277678-7/2/2 — L'Oreal USA Products IncAug 26, 2004 — United States
551-3277678-7/2/1 — L'Oreal USA Products IncAug 26, 2004 — United States
551-3277678-7/2/8 — L'Oreal USA Products IncAug 26, 2004 — United States
551-3277678-7/2/7 — L'Oreal USA Products IncAug 26, 2004 — United States
551-3277678-7/2/6 — L'Oreal USA Products IncAug 26, 2004 — United States
551-3277678-7/1/2 — L'Oreal USA Products IncAug 26, 2004 — United States
582-9736342-6/1/1 — Able Laboratories Inc.Jul 30, 2004 — United States
551-0627712-7/1/1A — Liz ClaiborneJul 26, 2004 — United States
551-0627712-7/1/1B — Liz ClaiborneJul 26, 2004 — United States
551-0627712-7/1/1C — Liz ClaiborneJul 26, 2004 — United States
551-0627712-7/1/1D — Liz ClaiborneJul 26, 2004 — United States
551-0627712-7/1/1E — Liz ClaiborneJul 26, 2004 — United States
551-0627712-7/1/1F — Liz ClaiborneJul 26, 2004 — United States
551-0627712-7/1/1G — Liz ClaiborneJul 26, 2004 — United States
551-0627712-7/1/1H — Liz ClaiborneJul 26, 2004 — United States
← Previous Page 29 of 32 Next →

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.